Skadden, Arps, Slate, Meagher & Flom, LLP and Arthur Cox LLP advised Strongbridge, while Goodwin Procter LLP and A&L Goodbody LLP advised Xeris on the deal....
Xeris Pharmaceuticals’ Acquisition of Strongbridge Biopharma
Xeris Pharmaceuticals’ Acquisition of Strongbridge Biopharma
Skadden, Arps, Slate, Meagher & Flom, LLP and Arthur Cox LLP advised Strongbridge, while Goodwin Procter LLP and A&L Goodbody LLP advised Xeris on the deal....
NIO’s $1.5 Billion Convertible Senior Notes Offering
Latham & Watkins represented the joint bookrunning managers on the deal, while Skadden advised NIO. NIO Inc (NYSE:NIO) executed its offering of US$750 million in aggregate principal...